Precept Management LLC Charles River Laboratories International, Inc. Transaction History

Precept Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $3.35 Million - $4.74 Million	-13,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $264,753 - $334,485	-900 Reduced 6.43%	13,100 $4.85 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $19 Million - $22.8 Million	-76,000 Reduced 84.44%	14,000 $4.06 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $1.11 Million - $1.26 Million	5,000 Added 5.88%	90,000 $22.5 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $1.35 Million - $1.74 Million	7,700 Added 9.96%	85,000 $19.2 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $8.91 Million - $14.2 Million	75,000 Added 3260.87%	77,300 $13.5 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $2.75 Million - $4.96 Million	-27,800 Reduced 92.36%	2,300 $290,000
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $957,980 - $1.16 Million	7,600 Added 33.78%	30,100 $4.6 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $308,500 - $371,375	2,500 Added 12.5%	22,500 $3.19 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $2.1 Million - $2.93 Million	20,000 New	20,000 $2.91 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

Stay updated on Precept Management LLC with notifications on news.